DermTech Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | no data |
| Proprietà del CEO | n/a |
| Durata media del management | 2.3yrs |
| Durata media del Consiglio di amministrazione | 5.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%
May 21
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate
Mar 02Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%
Mar 02Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price
Dec 28Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky
Sep 18Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?
Jun 14Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023
May 10DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%
May 06We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jan 16Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)
Nov 08Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?
Oct 11DermTech grants stock options
Oct 11Diving Into DermTech
Sep 01Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80
Aug 10DermTech: Approaching An All Or Nothing Moment
Jun 13We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jun 04DermTech - Taking A Second Look At The Growth Thesis
Mar 31DermTech: Adoption Headwinds And Earnings Misses
Dec 23Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth
Dec 02AMMINISTRATORE DELEGATO
DermTech non ha un CEO, o non abbiamo dati su di loro.
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | no data | US$480.83k | Nessun dato | |
| Head of Finance | no data | Nessun dato | Nessun dato | |
| Senior Director of Investor Relations | no data | Nessun dato | Nessun dato | |
| Chief Compliance Officer | 2.3yrs | Nessun dato | Nessun dato | |
| Chief Medical Officer | 3.4yrs | Nessun dato | Nessun dato |
2.3yrs
Durata media
Gestione esperta: Il team dirigenziale di DMTK.Q è considerato esperto (durata media dell'incarico 2.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Independent Director | 5.3yrs | US$149.64k | 0.28% $ 0.1 | |
| Independent Director | 2.3yrs | US$136.64k | 0.094% $ 0.03 | |
| Independent Chairman of the Board | 8.3yrs | US$188.64k | 0.35% $ 0.1 | |
| Independent Director | 2.3yrs | US$139.64k | 0.081% $ 0.03 | |
| Independent Director | 5.3yrs | US$156.64k | 0.20% $ 0.07 | |
| Member of Clinical Advisory Board | 7.1yrs | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 3.1yrs | US$134.64k | 0.092% $ 0.03 | |
| Member of Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | 5.8yrs | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | no data | Nessun dato | Nessun dato |
5.3yrs
Durata media
62yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di DMTK.Q sono considerati esperti (durata media dell'incarico 5.3 anni).